K260044 · Aesculap, Inc. · JXG · Oct 2, 2026 · Neurology
Device Facts
Record ID
K260044
Device Name
Ventricular Catheters, Thomale Catheter
Applicant
Aesculap, Inc.
Product Code
JXG · Neurology
Decision Date
Oct 2, 2026
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 882.5550
Device Class
Class 2
Attributes
Therapeutic, Pediatric
Indications for Use
The catheters are intended for cerebrospinal fluid (CSF) shunting.
Device Story
Ventricular catheters (Thomale Catheter) serve as components of the Miethke Shunt System for hydrocephalus treatment. Devices are implanted to provide a fluid pathway for CSF drainage. Catheters feature bullet-shaped tips with 6 or 16 inlet holes, depth markers, and radiopaque tantalum ink for visualization. Manufactured from barium sulfate-filled silicone elastomer. Used by neurosurgeons in clinical settings. Output is a physical conduit for CSF flow; clinical benefit is the management of intracranial pressure. Device articulates with existing Miethke shunt valves and reservoirs.
Clinical Evidence
Bench testing only. Performance evaluated per ISO 7197:2024, including kink testing and radiopacity. MRI safety testing performed per ASTM F2052, F2213, F2182, and F2119. Biocompatibility testing conducted per ISO 10993-1, covering cytotoxicity, sensitization, irritation, genotoxicity, implantation, acute systemic toxicity, sub-chronic toxicity, hemolysis, and pyrogenicity. Chronic toxicity and carcinogenicity addressed via chemical characterization and toxicological risk assessment.
Technological Characteristics
Materials: Barium sulfate-filled silicone elastomer (NUSIL MED14-4765, MED14-4750, MED-4860). Dimensions: 1.2 mm ID, 2.5 mm OD; 18 cm or 25 cm lengths. Features: Bullet-shaped tip, 6 or 16 inlet holes, tantalum ink depth markers. Sterilization: Steam. Connectivity: None (mechanical component).
Indications for Use
Indicated for cerebrospinal fluid (CSF) shunting in patients requiring hydrocephalus treatment, including adult, pediatric, and neonatal populations.
Regulatory Classification
Identification
A central nervous system fluid shunt is a device or combination of devices used to divert fluid from the brain or other part of the central nervous system to an internal delivery site or an external receptacle for the purpose of relieving elevated intracranial pressure or fluid volume (e.g., due to hydrocephalus). Components of a central nervous system shunt include catheters, valved catheters, valves, connectors, and other accessory components intended to facilitate use of the shunt or evaluation of a patient with a shunt.
{1}
**U.S. FOOD & DRUG**
ADMINISTRATION
October 2, 2026
Aesculap, Inc.
Kathy Racosky
Technical Manager II
3773 Corporate Pkwy.
Center Valley, Pennsylvania 18034
Re: K260044
Trade/Device Name: Ventricular Catheters, Thomale Catheter
Regulation Number: 21 CFR 882.5550
Regulation Name: Central Nervous System Fluid Shunt And Components
Regulatory Class: Class II
Product Code: JXG, HCA
Dated: September 2, 2026
Received: September 2, 2026
Dear Kathy Racosky:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding
{2}
K260044 - Kathy Racosky
Page 2
When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
{3}
K260044 - Kathy Racosky
Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
JULIA E. SLOCOMB -S Digitally signed by JULIA E. SLOCOMB -S Date: 2026.10.02 16:45:02 -04'00'
for Ryan Trombetta, Ph.D.
Assistant Director
DHT5A: Division of Neurosurgical,
Neurointerventional, and
Neurodiagnostic Devices
OHT5: Office of Neurological and
Physical Medicine Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{4}
| Indications for Use | | |
| --- | --- | --- |
| Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K260044 | ? |
| Please provide the device trade name(s). | | ? |
| Ventricular Catheters, Thomale Catheter | | |
| Please provide your Indications for Use below. | | ? |
| The catheters are intended for cerebrospinal fluid (CSF) shunting. | | |
| Please select the types of uses (select one or both, as applicable). | ☑ Prescription Use (Part 21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? |
Ventricular Catheters, Thomale Catheter
Page 17 of 125
{5}
K260044
# 510(k) SUMMARY (as required by 21 CFR 807.92)
# Ventricular Catheter, Thomale Catheter
October 1, 2026
COMPANY: Aesculap®, Inc.
3773 Corporate Parkway
Center Valley, PA 18034
Establishment Registration Number: 2916714
CONTACT: Kathy A. Racosky
610-984-7402 (phone)
kathy.racosky@aesculap.com
TRADE NAME: Ventricular Catheters, Thomale Catheter
COMMON NAME: Shunt, Central Nervous System And Components
Catheter, Ventricular
CLASSIFICATION: Class II
CLASSIFICATION NAME: Central Nervous System Fluid Shunt And Components
Ventricular catheter
REGULATION NUMBER: 882.5550, 882.4100
PRODUCT CODE: JXG, HCA
# Predicate device
Ventricular Catheter, K200950
# Indications for Use
The catheters are intended for cerebrospinal fluid (CSF) shunting.
# Device description
The Ventricular Catheter, Thomale Catheter are utilized as a component of the Miethke Shunt System(s) to treat hydrocephalus. It is available in two lengths: 18 cm or 25 cm with an inner diameter of 1.2 mm and an outer diameter of 2.5 mm. The 18 cm catheter is offered with either 6 or 16 flow holes at the proximal end, while the 25 cm catheter is supplied exclusively with 16 flow holes. To facilitate accurate placement, the Ventricular Catheter, Thomale Catheter incorporate five depth markers noted by numerical stripes at 3, 5, 7, 10 and 13 cm from the catheter tip. The Ventricular Catheter, Thomale Catheter are manufactured using barium sulfate filled silicone elastomer.
The purpose of this submission is to obtain clearance for modifications to the ventricular catheter component of the Miethke Shunt System (predicate device K200950). Specifically, this
Page 1 of 5
{6}
K260044
submission proposes two product updates: a newly designed ventricular catheter and a variant manufactured using alternative materials.
The Ventricular Catheter, Thomale Catheter are designed to articulate with existing Miethke Shunt Systems, specifically, M.blue Adjustable Shunt System, Miethke Shunt System GAV 2.0 and SA 2.0 Valves, proGAV 2.0 Adjustable Shunt System, Miethke Shunt System miniNAV valve, Miethke Shunt System (DSV, connectors, and reservoirs) cleared by FDA (K192266/K190174/K161853/K141687/K110206/K030698/K011030).
# **Technological Comparison (compared to Predicate(s))**
| Attributes | Subject device Ventricular Catheter, Thomale Catheter | Predicate device Ventricular Catheter K200950 | Equivalency Analysis |
| --- | --- | --- | --- |
| Product Code: | JXG | JXG | Identical to the predicate device. |
| Class: | II | II | Identical to the predicate device. |
| Regulation # | 882.5550 | 882.5550 | Identical to the predicate device. |
| Indications: | The catheters are intended for cerebrospinal fluid (CSF) shunting. | The catheter is used for cerebrospinal fluid (CSF) shunting. | Equivalent The subject device is substantially equivalent to the predicate device. Although there is a slight difference in the wording of the indications for use both devices share the same intended use: to provide a fluid pathway for the shunting of cerebrospinal fluid (CSF). Aligns with FDA terminology for Indications for Use, which describes the device's purpose rather than its actual usage. |
| Classification Name: | Central Nervous System Fluid Shunt and Components | Central Nervous System Fluid Shunt and Components | Identical to the predicate device. |
| Catheter Body Dimensions: | 1.2 mm ID (0.050") x 2.5 mm OD (0.100") | 1.2 mm ID (0.050") x 2.5 mm OD (0.100") | Identical to the predicate device. |
| Catheter Length: | 18 and 25 cm | 18 and 25 cm | Identical to the predicate device. |
| Catheter Markers: | -Numerical w/stripe at 3, 5, 7, 10 & 13 cm -Stripe at 4, 6, 8, 9, 11 & 12 cm -Dot between 3.5-12.5 cm at 1 cm intervals | -Numerical w/stripe at 3, 5, 7, 10 & 13 cm -Stripe at 4, 6, 8, 9, 11 & 12 cm -Dot between 3.5-12.5 cm at 1 cm intervals | Identical to the predicate device. |
| Marking: | Tantalum ink marker | Tantalum ink marker | Identical to the predicate device. |
Page 2 of 5
{7}
K260044
| Attributes | Subject device Ventricular Catheter Thomale Catheter | Predicate device Ventricular Catheter K200950 | Equivalency Analysis |
| --- | --- | --- | --- |
| **Catheter Tip:** | | | |
| Ventricular Catheter | Bullet shape with 16 inlet holes (4 rows of 4 holes) | Bullet shape with 16 inlet holes (4 rows of 4 holes) | Identical to the predicate device. |
| Thomale Catheter | Bullet shape with 6 inlet holes | Bullet shape with 16 inlet holes (4 rows of 4 holes) | Equivalent The subject device is substantially equivalent to the predicate device. It maintains the same bullet-shaped tip design, with a reduced number of inlet holes. |
| Close-up of Catheter Marking: | | | Identical to the predicate device. |
| **Close-up of Catheter Tip:** | | | |
| Ventricular Catheter | | | Identical to the predicate device. |
| Thomale Catheter | | | Equivalent The subject device is substantially equivalent to the predicate device. While the subject device features fewer flow holes, both devices are designed to facilitate fluid flow effectively. |
| **Materials:** | | | |
| Catheter tubing | - Silicone NUSIL MED14-4765 (contains Barium Sulfate BaSO₄) - Silicone NUSIL MED14-4750 (contains Barium Sulfate BaSO₄) | - Silicone NUSIL MED-4765 - Silicone NUSIL MED-2000 - Traces of Titanium Dioxide - Barium Sulfate BaSO₄ | Equivalent The subject device is substantially equivalent to the predicate device. Although it is manufactured using different materials, both devices utilize silicone elastomers. |
Page 3 of 5
{8}
K260044
| Attributes | Subject device Ventricular Catheter Thomale Catheter | Predicate device Ventricular Catheter K200950 | Equivalency Analysis |
| --- | --- | --- | --- |
| Catheter Tip | - Silicone NUSIL MED-4860 - Barium sulfate BaSO_{4} | - Silicone NUSIL MED-4860 - Barium sulfate BaSO_{4} | Identical to the predicate device. |
| Marking | - NUSIL MED2-4213 (binder for markings) - Tantalum Powder | - NUSIL MED2-4213 (binder for markings) - Tantalum Powder | Identical to the predicate device. |
| Specification of fillers in finished catheter | 9 – 20 % Barium Sulfate BaSO_{4} | - 9 – 20 % Barium Sulfate BaSO_{4} - Traces of Titanium Dioxide | Equivalent The subject device is substantially equivalent to the predicate device. They both have the same specification of Barium Sulfate filler in the finished catheter; both devices utilize fillers as whitening agents. |
| **Sterilization:** | Steam | Steam | Identical to the predicate device. |
| **Biocompatibility Assessment:** | Passed | Passed | Identical to the predicate device. |
| **ISO 7197 Testing:** | Passed | Passed | Identical to the predicate device. |
| **Radiopacity:** | Passed | Passed | Identical to the predicate device. |
| **Endotoxin Testing:** | < 2.15 EU/device | < 2.15 EU/device | Identical to the predicate device. |
### Non-Clinical and/or Clinical Tests Summary
The following performance data were provided in support of the substantial equivalence determination.
Performance Bench Testing:
Bench testing was conducted in accordance with ISO 7197:2024.
A dedicated performance evaluation was performed under kinked conditions.
Page 4 of 5
{9}
K260044
Radiopacity testing was conducted on the Ventricular Catheter, Thomale Catheter. The results demonstrate that the catheters are clearly identifiable under X-ray examination.
MRI Safety Testing was conducted in accordance with ASTM F2052, ASTM F2213, ASTM F2182, and ASTM F2119. The results support that the prechamber component is MR Conditional for use in 3-Tesla Magnetic Resonance Imaging systems, as defined by ASTM F2503.
Biocompatibility testing:
Biocompatibility evaluation was performed in accordance with ISO 10993-1 and the FDA-recognized guidance document, “Use of International Standard ISO 10993-1, Biological Evaluation of Medical Devices – Part 1: Evaluation and Testing within a Risk Management Process.”
Testing included the following endpoints:
- Cytotoxicity
- Sensitization
- Intracutaneous Irritation/Reactivity
- Genotoxicity
- Implantation
- Acute Systemic Toxicity
- Sub-chronic Toxicity
- Hemolysis
- Pyrogenicity
Chronic systemic toxicity and carcinogenicity endpoints were addressed through chemical characterization (extractable and leachable studies), followed by a biological risk assessment.
A toxicological risk assessment was also conducted to evaluate potential risks of chronic systemic toxicity, carcinogenicity, and developmental and reproductive toxicity associated with patient exposure to extractable compounds. This assessment considered use in adult, pediatric, and neonatal populations.
The Ventricular Catheter, Thomale Catheter, deflector, prechamber and CSF port are classified as implantable devices in contact with neural tissue and/or bone, cerebrospinal fluid (CSF), and blood (indirect blood contact through CSF (>30 days). The stylet is classified as an indirect contact device intended for tissue/bone contact of less than 1 hour.
## Conclusion:
All testing results confirm that the Ventricular Catheter, Thomale Catheter, as a component of the Miethke Shunt System, meets the acceptance criteria for the specified shelf life, conforms to ISO 7197, and are substantially equivalent to the predicate device.
Page 5 of 5
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Guidance alerts
New and changed FDA guidance documents, emailed as a daily digest.
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the ? button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only Software as a Medical Device, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (Software as a Medical Device), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.